1. Zappas, M.P., Gentes, M. and Walton.Moss, B. 2017. Use of incretin therapy in the treatment of type 2 diabetes mellitus. J Nurse Pract., 13: 418-424.
2. Kieffer, T.J., McIntosh, C. and Pederson, R.A. 1995. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinol., 136: 3585-3596.
3. Eng, J., Kleinman, W., Singh L., Singh, G. and Raufman, J.P. 1992. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. World J Biol Chem., 267: 7402-7405.
4. Chen, Y.E. and Drucker, D.J. 1997. Tissue-specific expression of unique mRNAs that encode proglucagon-derived peptides or exendin 4 in the lizard. World J Biol Chem., 272: 4108-4115.
5. Doyle, M.E., Theodorakis, M.J., Holloway, H.W., Bernier, M., Greig, N.H and Egan, J.M. 2003. The importance of the nine-amino acid C-terminal sequence of exendin-4 for binding to the GLP-1 receptor and for biological activity. Regul peptides., 114: 153-158.
6. Kim, D., MacConell, L., Zhuang, D., Kothare, P.A., Trautmann, M. and Fineman, M. 2007. Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes. Diabetes care., 30: 1487-1493.
7. DeFronzo, R.A., Ratner, R.E., Han, J., Kim, D.D., Fineman, M.S. and Baron, A.D. 2005. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes care., 28: 1092-1100.
8. Guo, L., Yin, R., Liu, K., Lv, X., Li, Y. and Duan, X. 2014. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model. Appl Microbiol Biotechnol., 98: 3495-3507.
9. Androutsellis.Theotokis, A., Walbridge, S., Park, D.M., Lonser, R.R. and McKay, R.D. 2010. Cholera toxin regulates a signaling pathway critical for the expansion of neural stem cell cultures from the fetal and adult rodent brains. PLoS One., 5: 10841.
10. Fischer, R., Schillberg, S. and Emans, N. 2001. Molecular farming of medicines: a field of growing promise. Outlook Agric., 30: 31-36.
11. Floss, D.M., Falkenburg, D and Conrad, U. 2007. Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Transgenic Res., 16: 315-332.
12. Hiatt, A. and Pauly, M. 2006. Monoclonal antibodies from plants: a new speed record. Proc Natl Acad Sci., 103: 14645-14646.
13. Kapila, J., DeRycke, R., Van Montagu, M. and Angenon, G. 1997. An Agrobacterium-mediated transient gene expression system for intact leaves. Plant Sci., 122: 101-108.
14. Kwon, KC., Nityanandam, R., New, J.S. and Daniell, H. 2013. Oral delivery of bioencapsulated exendin‐4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta‐TC6 cells. Plant Biotechnol J., 11: 77-86.
15. Sambrook, J. and Russell, D.W. 2006. Preparation and transformation of competent E. coli using calcium chloride. Cold Spring Harb Protoc., 2006: pdb. prot3932.
16. Höfgen, R. and Willmitzer. L. 1988. Storage of competent cells for Agrobacterium transformation. Nucleic Acids Res., 16: 9877.
17. Liu, Z.Z., Wang, J.L., Huang, X., Xu, W.H., Liu, Z.M. and Fang, R.X. 2003. The promoter of a rice glycine-rich protein gene, Osgrp-2, confers vascular-specific expression in transgenic plants. Planta., 216: 824-833.
18. Mazzara, M. and James, D.J. 2000. The influence of photoperiodic growth condition on isolation of RNA from strawberry (Fragaria× ananassa Duch.) tissue. Mol Biotechnol., 15: 237-241.
19. Kim, D., MacConell, L., Zhuang, D., Kothare, P.A., Trautmann, M. and Fineman, M. 2007. Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes. Diabetes care., 30: 1487-1493.
20. Jiang, J., Chen, Z. and Zhou, X. 2003. Production of a monoclonal antibody to sugarcane mosaic virus and its application for virus detection in China. J Phytopathol., 151: 361-364.
21. Goldberg, M and Gomez.Orellana, I. 2003. Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov., 2: 289.
22. Bond, A. 2006. Editor Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus. Proc (Bayl Univ Med Cent)., 19: 281-284.
23. Kumar, G.S., Ganapathi, T.R., Revathi, C.J., Prasad, K.S and Bapat, V.A. 2003. Expression of hepatitis B surface antigen in tobacco cell suspension cultures. Protein Expr Purif., 32: 10-17.
24. Gleba, Y., Klimyuk, V. and Marillonnet, S. 2007. Viral vectors for the expression of proteins in plants. Curr Opin Biotechnol., 18: 134-141.
25. Leckie, B.M. and Stewart, J.r.C.N. 2011. Agroinfiltration as a technique for rapid assays for evaluating candidate insect resistance transgenes in plants. Plant Cell Rep., 30: 325-334.
26. Jobling, S.A., Jarman, C., The, M.M., Holmberg, N., Blake, C and Verhoeyen, M.E. 2003. Immunomodulation of enzyme function in plants by single-domain antibody fragments. Nat Biotechnol., 21: 77.
27. Dhar, A.K., Robles-Sikisaka, R., Saksmerprome, V. and Lakshman, D.K. 2014. Biology, genome organization, and evolution of parvoviruses in marine shrimp. Adv Virus Res., 89: 85-139.